Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Infectious Diseases

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/649858PMID 20047480PMCID PMC5826644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

  2009cited by this paper
• Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

  2009cited by this paper
• Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

  2009cited by this paper
• Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures

  2009cited by this paper
• Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

  2009cited by this paper
• Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

  2008cited by this paper
• Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.

  2008cited by this paper
• Cryptococcosis in solid organ transplant recipients: current state of the science.

  2008cited by this paper
• Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

  2008cited by this paper
• Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era

  2008cited by this paper
• Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease

  2008cited by this paper
• Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

  2008cited by this paper
• High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.

  2008cited by this paper
• Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

  2008cited by this paper
• Emergence of Cryptococcus gattii in the Pacific Northwest United States

  2008cited by this paper
• [Cryptococcosis in renal transplant recipients].

  2007cited by this paper
• Coccidioidomycosis and pregnancy: a review.

  2007cited by this paper
• Serologic Evidence for Reactivation of Cryptococcosis in Solid-Organ Transplant Recipients

  2007cited by this paper
• Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.

  2007cited by this paper
• Post partum osteomyelitis due to Cryptococcus neoformans

  2007cited by this paper
• Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

  2007influential reference
• Immune reconstitution syndrome associated with opportunistic mycoses.

  2007cited by this paper
• Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study

  2007cited by this paper
• Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients

  2007cited by this paper
• Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children

  2007cited by this paper
• Cryptococcosis and Idiopathic CD4 Lymphocytopenia

  2007cited by this paper
• Immune reconstitution syndrome and exacerbation of infections after pregnancy.

  2007cited by this paper
• Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.

  2007influential reference
• Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda

  2007cited by this paper
• Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis.

  2007cited by this paper
• Cryptococcosis.

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of antifungals.

  2006cited by this paper
• Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.

  2006cited by this paper
• Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.

  2006cited by this paper
• Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

  2006cited by this paper
• Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

  2006influential reference
• In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs

  2006cited by this paper
• Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

  2006cited by this paper
• Fungal brain abscesses in leukemia.

  2006influential reference
• Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children

  2006cited by this paper
• Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004.

  2006cited by this paper
• Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence

  2006cited by this paper
• Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with Cryptococcosis

  2006cited by this paper
• Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer.

  2006cited by this paper
• The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy.

  2006cited by this paper
• Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome

  2006cited by this paper
• Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis

  2006cited by this paper
• Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

  2006cited by this paper
• Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans

  2006cited by this paper
• The periodic health examination

  2006cited by this paper
• Long-Term Outcome

  2005cited by this paper
• Are Adverse Events of Nevirapine and Efavirenz Related to Plasma Concentrations?

  2005cited by this paper
• Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.

  2005cited by this paper
• Fungal infections in transplant recipients receiving alemtuzumab.

  2005cited by this paper
• An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.

  2005cited by this paper
• Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

  2005cited by this paper
• Disseminated infection with Cryptococcus neoformans var neoformans in an 8 years immunocompetent girl.

  2005cited by this paper
• Nine-year-old girl with lymphangiectasia and chest pain.

  2005cited by this paper
• Managing cryptococcal meningitis is about handling the pressure.

  2005cited by this paper
• The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.

  2005cited by this paper
• The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy.

  2005cited by this paper
• Efficacy and Safety of Amphotericin B Lipid Complex in 548 Children and Adolescents With Invasive Fungal Infections

  2005cited by this paper
• Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.

  2005cited by this paper
• Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.

  2005cited by this paper
• Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease.

  2005cited by this paper
• Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak

  2005cited by this paper
• Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

  2005cited by this paper
• Antifungal Management Practices and Evolution of Infection in Organ Transplant Recipients with Cryptococcus Neoformans Infection

  2005influential reference
• Activity of posaconazole in the treatment of central nervous system fungal infections.

  2005cited by this paper
• Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.

  2005cited by this paper
• Management of cryptococcosis in non-HIV-related patients.

  2005cited by this paper
• Interrupción exitosa de la profilaxis secundaria antifúngica en la criptococosis asociada al SIDA

  2004cited by this paper
• Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.

  2004cited by this paper
• Mother-to-child transmission of cryptococcus neoformans.

  2004cited by this paper
• Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman.

  2004cited by this paper
• Th2/Th3 cytokine genotypes are associated with pregnancy loss.

  2004cited by this paper
• Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

  2004influential reference
• [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].

  2004cited by this paper
• Cryptococcus Infection in Tropical Australia

  2004cited by this paper
• Reducing intracranial pressure may increase survival among patients with bacterial meningitis

  2004cited by this paper
• Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients.

  2004cited by this paper
• Reducing intracranial pressure may increase survival among patients with bacterial meningitis.

  2004cited by this paper
• A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

  2004cited by this paper
• Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

  2004cited by this paper
• Cryptococcosis in HIV-infected children.

  2004cited by this paper
• Recombinant Interferon-γlb as Adjunctive Therapy for AIDS-Related Acute Cryptococcal Meningitis

  2004cited by this paper
• Voriconazole treatment for less-common, emerging, or refractory fungal infections.

  2003cited by this paper
• Pulmonary Cryptococcosis After Initiation of Anti-Tumor Necrosis Factor-α Therapy

  2003cited by this paper
• Pulmonary cryptococcosis in nonimmunocompromised patients.

  2003cited by this paper
• The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

  2003cited by this paper
• Primary cutaneous cryptococcosis: a distinct clinical entity.

  2003cited by this paper
• Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.

  2003cited by this paper
• Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda.

  2003cited by this paper
• Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy.

  2003cited by this paper
• A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.

  2002cited by this paper
• Cryptococcal Meningitis in a Neonate

  2002cited by this paper
• Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

  2002influential reference
• A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis.

  2002cited by this paper
• Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.

  2002cited by this paper
• Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy.

  2002cited by this paper

• Cryptococcus neoformans infection presenting as a mediastinal mass in an immunocompetent child with parrot exposure: a case report and literature review

  2026cites this paper
• Comparison of the Efficacy and Safety of Different Antifungal Regimen Combinations in Non-HIV and Non-transplant Cryptococcal Meningitis Patients with High Cryptococcal Count

  2026cites this paper
• Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital

  2026cites this paper
• Recurrence of HIV-associated cryptococcal meningitis in pregnancy and the post-partum period.

  2026cites this paper
• Dual inhibition of ERG11 and CDR2 in drug-resistant Candida albicans by Indian phytochemicals: a combined in silico–in vitro approach

  2026cites this paper
• India ink-negative and culture-negative cryptococcal meningitis in HIV-negative patients

  2026cites this paper
• Update on the diagnosis, pathophysiology and treatment strategies in non-HIV-associated cryptococcal meningoencephalitis

  2026influential citation
• Intralobar pulmonary sequestration coexisting with pulmonary cryptococcosis: A case report and literature review

  2026cites this paper
• An Unusual Case of Cryptococcal Meningitis in an Immunocompetent 5-Year-Old: A Case Report

  2026cites this paper
• Imaging evaluation and management of liver infections: a multimodality review.

  2026cites this paper
• Serum cryptococcal antigen gradient detection for monitoring the efficacy and medical guidance of the treatment of pulmonary cryptococcosis: a case report

  2026cites this paper
• Extracellular Basophilic Material in Histopathology: A Pattern-based Diagnostic Approach with Case Illustrations

  2026cites this paper
• Rethinking Routine Lumbar Puncture and Induction Therapy in Non-HIV Pulmonary Cryptococcosis: A Call for Risk-Based Management

  2026cites this paper
• Omics approaches in Cryptococcosis: Molecular insights into host alterations

  2026cites this paper
• Cryptococcosis in Colombia: Analysis of Data from Laboratory-Based Surveillance 2017–2024

  2026cites this paper
• Cryptococcal meningitis complicating immunomodulatory drug maintenance therapy in patients with multiple myeloma: a report of two cases

  2026cites this paper
• Immunocompetent but Not Immune: A Prolonged Course of Cryptococcal Meningitis

  2026cites this paper
• Case 4-2026: An 80-Year-Old Woman with Cough and Hypoxemia.

  2026cites this paper
• Cryptococcus neoformans causing localised osteomyelitis of the right anterior rib

  2026cites this paper
• Clinical spectrum, immune status, and prognostic factors of cryptococcosis: insights from a large, multi-center, ambispective cohort study in southeastern China

  2026cites this paper
• Association Between the Systemic Immune-Inflammation Index and 24-week Outcomes in Patients with HIV-Associated Cryptococcal Meningitis: Secondary Analysis of a Prospective Multicenter Cohort Study

  2025influential citation
• Cryptococcal Meningitis in an HIV-Negative, Lymphoma Survivor: A Case Report of an Uncommon Dual Pathology

  2025influential citation
• Cryptococcal pericarditis with unexplained lymphadenopathy in an immunocompetent patient: a case report

  2025cites this paper
• Analysis of clinical characteristics and prognostic factors in AIDS complicated by cryptococcal meningitis

  2025cites this paper
• Current and emerging therapies for fungal biofilms and systemic infections

  2025cites this paper
• Target product profile and discovery and development path for novel cryptococcal disease treatments.

  2025cites this paper
• Disseminated cryptococcosis involving the adrenal gland and brain in an immunocompetent patient: A case report

  2025cites this paper
• Multifocal Intracranial Cryptococcoma with Treatment Resistance, Recurrence, and Mortality: A Case Report and Literature Review

  2025cites this paper
• Imitating Shadows: Pulmonary Cryptococcosis Masquerading as Miliary Tuberculosis—A Rare Case

  2025cites this paper
• Evaluation of a lateral flow immunochromatographic assay for detecting cryptococcal antigens in bronchoalveolar lavage fluid from HIV-negative patients with pulmonary cryptococcosis

  2025cites this paper
• New antifungal strategies and drug development against WHO critical priority fungal pathogens

  2025cites this paper
• Musculoskeletal Manifestations of Disseminated Fungal Infections

  2025cites this paper
• Bilateral Cerebellar Hemispheric Ischemia in Cryptococcal Meningitis

  2025cites this paper
• Spontaneous Remission of Diffuse Large B-Cell Lymphoma in a Patient with AIDS

  2025cites this paper
• Cryptococcal immune reconstitution inflammatory syndrome: Cutaneous clues to disseminated cryptococcosis in a human immunodeficiency virus patient coinfected with tuberculosis on antiretroviral therapy

  2025influential citation
• Diagnosis of cryptococcal meningitis in people living with HIV in low-income countries: barriers and strategies

  2025cites this paper
• Riboflavin inhibits growth and reduces virulence of Cryptococcus neoformans in vitro by membrane disruption and excessive accumulation of reactive oxygen species and exhibits efficacy against pulmonary cryptococcosis and meningitis

  2025cites this paper
• Genomic Characterization of Cryptococcus neoformans Isolated from Zebra Dove Excreta in Songkhla, Thailand

  2025cites this paper
• Non-acquired immunodeficiency syndrome-related cryptococcal meningitis with recurrent acute stroke: A case report

  2025cites this paper
• A multicenter prospective clinical cohort study of pulmonary cryptococcosis in adult non-HIV-infected patients in a southeastern province of China

  2025cites this paper
• Clinical-imaging and therapeutic evaluation of nodule-mass pulmonary cryptococcosis and pneumonia-type pulmonary cryptococcosis

  2025cites this paper
• Neuroimaging findings of disseminated cryptococcosis in children and correlation with prognosis

  2025cites this paper
• Overcoming the Diagnostic Challenges in Cutaneous Cryptococcosis Caused by Cryptococcus neoformans: A Case Study Utilizing Metagenomic Next-Generation Sequencing

  2025influential citation
• Research progress on immunometabolism and gut microbiota in cryptococcal meningitis: mechanisms and therapeutic implications

  2025cites this paper
• Fungal Infections of Joints: the Current State of the Issue

  2025cites this paper
• Immunophenotyping of apparently immunocompetent hosts with cryptococcosis reveals IL-17 deficiency as a unifying susceptibility factor.

  2025cites this paper
• Effects of novel organoantimony compounds on the fungal pathogen Cryptococcus neoformans

  2025cites this paper
• Disseminated Cryptococcosis With Multifocal Osteomyelitis Presenting as a Non‐Healing Ulcer in a Kidney Transplant Recipient

  2025cites this paper
• Advancing antifungal therapy: exploring targeted CFW-PEc-enhanced ethosomal formulations of amphotericin B against cryptococcal pneumonia

  2025cites this paper
• High risk and low incidence diseases: Meningococcal disease.

  2025cites this paper
• Eyelid Ptosis as an Atypical Manifestation of Meningeal Cryptococcosis: A Case Report

  2025cites this paper
• In vitro susceptibility of C. neoformans isolates against FLU from HIV-negative CM patients in Guangdong, China.

  2025cites this paper
• A series of cryptococcal meningitis cases

  2025cites this paper
• A case displaying the importance of JAK1 and JAK2 gene transcription in antifungal defense against coccidioidomycosis

  2025cites this paper
• Emerging Cryptococcosis cases in Himalayan & Sub-Himalayan regions of India

  2025cites this paper
• A Contemporary Multidimensional Insight into the Clinical and Pathological Presentation of Urological Conditions Associated with HIV: A Narrative Review

  2025cites this paper
• Rhodotorula spp. in Laboratory and Veterinary Clinical Practice: Contamination or an Emerging Problem?

  2025cites this paper
• Star-Shaped Glatiramer Acetate Mitigates Pulmonary Dysfunction and Brain Neuroinflammation in a Murine Model of Cryptococcus-Associated IRIS

  2025cites this paper
• Central nervous system cryptococcosis with brain stem hemorrhage during chemotherapy for pediatric acute myeloblastic leukemia patient.

  2025cites this paper
• Pulmonary cryptococcosis coexisting with lung cancer: a Chinese multicenter retrospective study

  2025cites this paper
• Microbial heterogeneity-mediated treatment evasion and the potential for engineered live biotherapeutic products.

  2025cites this paper
• Cryptococcosis in kidney transplant recipients: Pathogenesis, clinical challenges, and evolving therapeutic strategies.

  2025cites this paper
• Disseminated cryptococcosis with renal involvement as the initial presentation of HIV infection

  2025cites this paper
• Uncovering the antifungal potential of Cannabidiol and Cannabidivarin

  2025cites this paper
• Addison’s disease due to adrenal insufficiency in an immunocompetent patient with disseminated cryptococcosis. Case report

  2025cites this paper
• Need for Change in the Quality of Antimicrobial Stewardship Team Recommendations Highlighted by a Case Report of Cryptococcus neoformans Meningoencephalitis

  2025cites this paper
• Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies.

  2025cites this paper
• On-Resin Assembly of Macrocyclic Inhibitors of Cryptococcus neoformans May1: A Pathway to Potent Antifungal Agents

  2025cites this paper
• Cryptococcus albidus meningitis: A case report and literature review

  2025cites this paper
• Induction Treatment for HIV-Associated Cryptococcal Meningitis: Where Have We Been and Where Are We Going?

  2025influential citation
• Activity and Safety Optimization of Mesoricin: A Dual-Domain Antifungal Peptide from Mesorhizobium sp.

  2025cites this paper
• Construction of a nomogram model based on multiple factors to differentiate cryptococcal meningitis from tuberculous meningitis in HIV-Infected patients

  2025cites this paper
• Fungal Pericarditis—A Systematic Review of 101 Cases

  2025cites this paper
• Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects

  2025cites this paper
• Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection.

  2025cites this paper
• Intracranial Cryptococcoma Mimicking Stroke or Brain Tumor: A Diagnostic Challenge in an Immunocompetent Patient

  2025cites this paper
• Elevated UDP-glucuronic acid levels mend drug resistance and stress responses via a protease and a transporter in Cryptococcus gattii

  2025cites this paper
• Insights on antifungal therapeutic drug monitoring from infectious diseases physicians and hospital‐based pharmacists: A focus group analysis

  2025cites this paper
• Pulmonary Cryptococcosis During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR) L858R-Mutant Lung Adenocarcinoma: A Case Report

  2025cites this paper
• Lead Optimization and Target Identification of Carboline Antifungal Agents.

  2025cites this paper
• The Patterns and Appropriateness of Systemic Antifungal Prescriptions in a Regional Hospital in Hong Kong

  2025cites this paper
• Cryptococcal Endocarditis in Humans—A Narrative Review

  2025cites this paper
• Evaluating clinical outcome in non-HIV associated cryptococcal meningitis with negative CSF culture using microscopic quantitative cryptococcal counting.

  2025cites this paper
• An atypical presentation of immune reconstitution inflammatory syndrome (IRIS) in a patient with cryptococcal meningitis in the setting of fingolimod therapy for multiple sclerosis

  2025cites this paper
• Pathogenic Features, Experimental Models, and Molecular Tools of Human Fungal Pathogens: Who's on WHO's Radar?

  2025cites this paper
• Cryptococcosis in Pediatric Renal Transplant Recipients: Comparative Insights from Adult Cases

  2025cites this paper
• Innovative Nanomedicine for Fungal Infections: Advancing Treatments Through Nanotechnology and Mycological Approaches

  2025cites this paper
• Clinical-imaging diversity of exudative pulmonary cryptococcosis with different immune states

  2025cites this paper
• A Review of Bioactive Plant Compounds Against WHO Priority Fungal Pathogens.

  2025cites this paper
• Diagnostic accuracy of laboratory methods for infectious meningitis and encephalitis

  2025cites this paper
• Foxp3+ Regulatory T Cells Restrain Th1 Response Shielding the Brain from Lethal Inflammatory Damage during Cryptococcal Meningoencephalitis

  2025cites this paper
• Case Report: combined surgical and pharmacological management of basal ganglia cryptococcal meningoencephalitis

  2025cites this paper
• Co-Infection of Pulmonary Aspergillosis and Cryptococcal Meningitis in an HIV-Positive Patient: A Case Report

  2025cites this paper
• Cryptococcus gattii meningitis in an immunocompromised patient in a hospital in the Peruvian Amazon: case report

  2025cites this paper
• Naganishia albidus Causing Perioral Cutaneous Infection: A Rare Case Easily Misdiagnosed

  2025cites this paper
• Repurposing the Anti-Fungal Drug Itraconazole for the Treatment of Skin Cutaneous Melanoma: An in-Silico Study

  2025cites this paper
• Acute Toxicity and Genotoxicity of cMoL, a Lectin From Moringa oleifera Seeds With Antifungal Activity Against Cryptococcus Strains

  2025cites this paper
• Meningeal abnormalities: a radiologist's guide to comprehensive imaging and differential diagnosis

  2025cites this paper
• Pulmonary Cryptococcosis due to Cryptococcus laurentii Co-infection with Miliary Tuberculosis in Adolescent Patient in Indonesia: Case Report

  2025cites this paper
• Fluconazole Resistance and Heteroresistance in Cryptococcus spp.: Mechanisms and Implications

  2025cites this paper